Cell therapy company Gamida Cell announced General Counsel and Chief Compliance Officer Josh Patterson will depart, effective April 26.

Cell therapy company Gamida Cell announced General Counsel and Chief Compliance Officer Josh Patterson will depart, effective April 26.